Profilo
Thomas D.
Willis was the founder of ParAllele BioScience, Inc. since 2001, serving as Chief Scientific Officer from 2001 to 2013.
Dr. Willis is the founder of Sequenta, Inc. since 2007, serving as Chief Executive Officer.
Current jobs include Chief Executive Officer at Arima Genomics, Inc. since 2025 and Venture Partner at IIF Management Co. LLC since 2017.
Former jobs include Director at Boreal Genomics, Inc., Director at SpinX Technologies SA, Vice President-DNA Product Marketing at Affymetrix, Inc. in 2007, and Principal at Stanford Genome Technology Center from 1996 to 2013.
Education includes graduate and doctorate degrees from Stanford University and an undergraduate degree from Yale University.
Posizioni attive di Thomas D. Willis
| Società | Posizione | Inizio |
|---|---|---|
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Amministratore Delegato | 18/08/2010 |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/01/2017 |
Arima Genomics Inc.
Arima Genomics Inc. BiotechnologyHealth Technology Engages in research, development and testing of cancer diagnostics | Amministratore Delegato | 17/06/2025 |
Precedenti posizioni note di Thomas D. Willis
| Società | Posizione | Fine |
|---|---|---|
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Direttore/Membro del Consiglio | 12/08/2010 |
| AFFYMETRIX, INC. | Vendite & Marketing | 01/01/2007 |
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Presidente | - |
Stanford Genome Technology Center | Corporate Officer/Principal | - |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Amministratore Delegato | - |
Formazione di Thomas D. Willis
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Commercial Services |
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status | Health Technology |
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Develops and markets DNA and RNA purification, enrichment, and detection equipment and tools | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures laboratory equipment | Health Technology |
Stanford Genome Technology Center | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Arima Genomics Inc.
Arima Genomics Inc. BiotechnologyHealth Technology Engages in research, development and testing of cancer diagnostics | Health Technology |
















